2005 Packaging Therapies Treatment 
The Pharma Data
NOVEMBER 2, 2020
Oncopeptides is a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases. Food and Drug Administration, FDA, for accelerated approval of melflufen in combination with dexamethasone for treatment of adult patients with triple-class refractory multiple myeloma.
Drug Discovery World
SEPTEMBER 29, 2022
Earlier this month, The Biden Administration announced plans for a $2 billion funding package for the biotechnology and manufacturing sector, to ensure a ‘sustainable, safe, and secure American bioeconomy’. Biden’s $2 billion biotech boost. billion over the period 2008–2020 2. Customer-focused leadership. UK-based H.E.L
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Codon
APRIL 9, 2024
However, the blandly clinical package of artemisinin and artesunate tablets reveals little about how the key compound was first discovered. In response to the precipitous rise in incidence, governments on both sides of the Pacific began a systematized search for antimalarial treatments.
Drug & Device Law
MAY 30, 2022
The plaintiffs’ causation allegations foundered in Himes because the treating physician did not believe that the claimed risks of electroconvulsive therapy were all that big of a deal, and thus did not warn about it. April 1, 2022) (the companion case to this ). at *3 (emphasis original). Hoffman-LaRoche, Inc. , 2d 806, 817 (5th Cir.
Drug & Device Law
JUNE 6, 2022
Thus a confident learned intermediary’s testimony will defeat causation as a matter of law by stating that, notwithstanding a poor result, the treatment provided was standard of care, and even in hindsight they would not do anything different. Confident learned intermediaries stand by their medical decisions. Novartis Pharmaceuticals Corp. ,
Expert insights. Personalized for you.
40 
Let's personalize your content